In the present study, our results suggested that treatment with minocycline was able to inhibit the NF-κB pathway, attenuate neuroinflammation and alleviate IFS-induced behavioral disturbances in rats. The gene discussed is NFKB1; the disease is congenital fibrosarcoma.